Benitec Biopharma Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Benitec Biopharma Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Hayward
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- June
- Ticker symbol
- BNTC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001808898
Board of directors
-
Aaron Cowen · DirectorSince 2024
-
David Matthew Friedman · DirectorSince 2026
-
Edward F. Smith · DirectorSince 2023
-
J. Kevin Buchi · DirectorSince 2023
-
Jerel A. Banks · Director · Chief Executive OfficerSince 2023
-
Kishan Mehta · DirectorSince 2024
-
Megan Boston · Director · Chief Financial OfficerSince 2023
-
Peter Francis · DirectorSince 2023
-
Sharon Mates · DirectorSince 2025
Chief executives
Jerel A. Banks
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of December 1, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
97.5%
-
99.5%
Board connections
5 of this board's directors also sit on 5 other boards.
- via Aaron Cowen and David Matthew Friedman
- via J. Kevin Buchi
- via David Matthew Friedman
- via Kishan Mehta
- via Sharon Mates
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $22,442,099
- 14 purchases by 2 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 29, 2026 | J. Kevin Buchi Director | Gift | −51,813 | — | — |
| Dec 29, 2025 | Aaron Cowen Director, 10% owner | Open-market purchase | +65,800 | $13.44 | $884,352 |
| Dec 29, 2025 | Aaron Cowen Director, 10% owner | Open-market purchase | +11,587 | $13.44 | $155,729 |
| Dec 26, 2025 | Aaron Cowen Director, 10% owner | Open-market purchase | +14,320 | $13.10 | $187,592 |
| Dec 26, 2025 | Aaron Cowen Director, 10% owner | Open-market purchase | +2,516 | $13.10 | $32,960 |
| Dec 23, 2025 | Aaron Cowen Director, 10% owner | Open-market purchase | +42,600 | $12.85 | $547,410 |
| Dec 23, 2025 | Aaron Cowen Director, 10% owner | Open-market purchase | +7,400 | $12.85 | $95,090 |
| Dec 22, 2025 | Aaron Cowen Director, 10% owner | Open-market purchase | +16,650 | $12.08 | $201,132 |
| Dec 22, 2025 | Aaron Cowen Director, 10% owner | Open-market purchase | +2,892 | $12.08 | $34,935 |
| Dec 19, 2025 | Aaron Cowen Director, 10% owner | Open-market purchase | +13,950 | $11.48 | $160,146 |
| Dec 19, 2025 | Aaron Cowen Director, 10% owner | Open-market purchase | +2,434 | $11.48 | $27,942 |
| Dec 18, 2025 | Aaron Cowen Director, 10% owner | Open-market purchase | +8,700 | $11.24 | $97,788 |
| Dec 18, 2025 | Aaron Cowen Director, 10% owner | Open-market purchase | +1,515 | $11.24 | $17,029 |
| Nov 7, 2025 | SUVRETTA CAPITAL MANAGEMENT, LLC Director, 10% owner | Open-market purchase | +730,370 | $13.50 | $9,859,995 |
| Nov 7, 2025 | SUVRETTA CAPITAL MANAGEMENT, LLC Director, 10% owner | Open-market purchase | +751,111 | $13.50 | $10,139,999 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.